Published by Kip A. Petroff, the founding and senior partner at Petroff & Associates in Dallas, Texas focusing on the representation of people injured by the weight loss drugs commonly known as Fen Phen.

Fen-phen all over again?

21 Feb
FDA still has concerns over Qnexa, but push is on for drug approval The obesity drug Qnexa is in the news this week as its maker, Vivus, Inc., tries to convince a concerned FDA Advisory Panel that the drug is safe and effective.  FDA officials still have safety concerns about this experimental diet pill.  The Read more
Read more
No comments

The Trust’s new interpretation of the Fen-Phen Settlement Agreement does not bode well for Claimants

9 Feb
In recent posts we have mentioned the Trust’s increasingly aggressive stance against claimants when evaluating claims. This approach has resulted in situations where the Trust sometimes seems to ignore or reinterpret the strict requirements of the Settlement Agreement. Class Counsel sometimes joins with the Trust on these new interpretations and it seems Class Counsel rarely, Read more
Read more
One comment